Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO Post author:Sam Post published:November 7, 2017 Post category:BioPharma OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company. Source: BioSpace You Might Also Like AbbVie's PARP Inhibitor Fails to Deliver in Two Late-Stage Studies April 19, 2017 GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen November 21, 2017 Pfizer Continues $190 Million Expansion Plans in North Carolina February 20, 2017